AWA
CNMD icon

Arkadios Wealth Advisors’s CONMED CNMD Stock Holding History

Arkadios Wealth Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-35
Closed -$4K – 1893
2021
Q2 		$4K Hold
35
– – ﹤0.01% 1759
2021
Q1 		$4K Hold
35
– – ﹤0.01% 1402
2020
Q4 		$3K Buy
+35
New +$3.31K ﹤0.01% 1191

Other funds holding CNMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Arkadios Wealth Advisors's CNMD Position: Q3 2021 in Review

Arkadios Wealth Advisors sold out of CONMED (CNMD) in Q3 2021, closing a stake of 35 shares — an estimated $4K sold.

Arkadios Wealth Advisors first reported a position in CNMD in Q4 2020 and held it in 3 quarters. The position peaked at $4K in Q2 2021. 262 funds tracked by Wall St. Rank hold CNMD as of Q3 2021.

  • Arkadios Wealth Advisors reported no remaining CONMED position as of Q3 2021 after selling out during the quarter.
  • Arkadios Wealth Advisors sold 35 CONMED shares in Q3 2021, an estimated $4K.
  • Arkadios Wealth Advisors first reported a position in CONMED in Q4 2020 and held it in 3 quarters.
  • Arkadios Wealth Advisors's CONMED position peaked at $4K in Q2 2021.
  • 262 funds tracked by Wall St. Rank held CONMED as of Q3 2021.

Based on Arkadios Wealth Advisors's 13F filing for Q3 2021, filed 19 Oct 2021.